Product analysis
Magnesium Triple Source supplies magnesium and B6 to help fill nutritional gaps and support normal metabolism, with magnesium also supporting bones and nerves. The undisclosed balance of magnesium forms makes its likely absorption harder to judge.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality38
The magnesium mix includes forms with different absorption potential. Because their proportions are undisclosed, the presence of citrate and malate does not establish how well the whole blend will be absorbed.
Ingredient Transparency80
The nutrient amounts and magnesium forms are identified, so the basic serving is clear. The amount of each magnesium form is missing, limiting a meaningful comparison of the blend.
Value For Money47
Magnesium's value is moderate and depends on an unknown balance of forms. B6 cannot be reliably compared for cost, leaving the overall value uncertain.
Customer Satisfaction91
Customer ratings are very positive across a sizeable set of reviews. That supports confidence in reported satisfaction, without proving the supplement's health effects.
Product Focus72
The clearest use is filling a magnesium gap to support normal metabolism, bones and nerves. The 500 mg serving exceeds the comparison amounts used for several goals, without establishing added benefit or suitability at that amount.
- Format
Tablet - Container
- 100 Tablet(s)
- Per serving
- $0.13
- Customer rating
- 4.9 · 3,010 ratings
Goals
No linked studies yet.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Vitamin B6 (Pyridoxine Hydrochloride) | 5 mg | |
Magnesium (Magnesium Citrate, Magnesium Malate, Magnesium Oxide) | 500 mg |
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Association between Serum Magnesium and Fractures: A Systematic Review and Meta-Analysis of Observational Studies.
- Bioabsorbable Magnesium-Based Materials Potential and Safety in Bone Surgery: A Systematic Review.
- Vascularized bone grafting fixed by biodegradable magnesium screw for treating osteonecrosis of the femoral head.
- An update on magnesium and bone health.
- Sex-specific differences in the association of magnesium intake with femoral neck bone mineral density among older adults.
- The Effects of the AGE Inhibitor Pyridoxamine on Bone in Older Women With Type 2 Diabetes: A Randomized Clinical Trial.
- Dietary B vitamin intake and risk of hip fracture: the Singapore Chinese Health Study.
- Hip fracture patients may be vitamin B6 deficient. Controlled study of serum pyridoxal-5'-phosphate.
- Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls.
- Adequate Intake and Supplementation of B Vitamins, in Particular Folic Acid, can Play a Protective Role in Bone Health.
- Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies.
- Magnesium and the risk of cardiovascular events: a meta-analysis of prospective cohort studies.
- Quantitative Association Between Serum/Dietary Magnesium and Cardiovascular Disease/Coronary Heart Disease Risk: A Dose-Response Meta-analysis of Prospective Cohort Studies.
- Comparative Efficacy of Nutraceuticals on Endothelial Function: A Systematic Review and Network Meta-Analysis.
- Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis.
- Association between serum pyridoxal 5'-phosphate levels and all-cause, cardiovascular mortality, and cardiovascular disease in adults: a population-based cohort study.
- Folate and vitamin B6 rapidly normalize endothelial dysfunction in children with type 1 diabetes mellitus.
- Pyridoxine improves endothelial function in cardiac transplant recipients.
- Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women.
- Efficacy and safety of pyridoxal 5'-phosphate (MC-1) in high-risk patients undergoing coronary artery bypass graft surgery: the MEND-CABG II randomized clinical trial.